Cytokines, neurotrophins, and oxidative stress in brain disease from mucopolysaccharidosis IIIB
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Mucopolysaccharidosis IIIB (MPS IIIB; Sanfilippo syndrome type B) is characterized by profound neurological deterioration. Because a murine model of MPS IIIB disease is available, we focused on analysis of gene expression in the brain and cerebellum of 7‐month‐old MPS IIIB mice by pathway‐specific filter microarrays designed to probe apoptotic‐related, neurotrophic signalling molecules and inflammatory cytokines and receptors. Moreover, we extended the analysis with real‐time PCR performed at 1, 3, 7 months after birth. Bdnf was down‐regulated in the brain but up‐regulated in the cerebellum at 7 months of age, both at RNA and at protein levels. Cbln1 presented a threefold increase in the oldest brains while remaining unaltered in the cerebellum. Ccl3, Casp11, gp91 phox, p67 phox, and p47 phox showed an increased expression in both brain and cerebellum at each examined time point. Ccl3, in particular, exhibited in both organs and at all times tested approximately a tenfold increase in its expression. Insofar as p47 phox, p67 phox, and gp91 phox are all components of the phagocyte NADPH oxidase, our results suggest the possible involvement of the reactive oxygen species in the genesis of neurodegeneration in MPS IIIB disease. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sairanen, M., Lucas, G., Ernfors, P., Castrén, M., & Castrén, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3741-04.2005 · Cited by 763 · cited 1×
“In particular, the hippocampus, which retains a high degree of plasticity and vulnerability throughout life, is one of the regions where Bdnf is expressed at high basal levels in the mature brain (Sairanen et al., 2005).”
BackgroundEssential role of brain-derived neurotrophic factor in adult hippocampal function
Monteggia, L. M., Barrot, M., Powell, C. M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R. W., & Nestler, E. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402141101 · Cited by 685 · cited 2×
“The loss of Bdnf during development causes hyperactivity and more pronounced hippocampal-dependent learning deficits (Monteggia et al., 2004) as well as hippocampaldependent memory impairment (Barrientos et al.”
BackgroundChung, C. Y., Seo, H., Sonntag, K. C., Brooks, A., Lin, L., & Isacson, O. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi178 · Cited by 361 · cited 2×
“2-fold more than in the A10 neurons, and it is known that A9 cells are more vulnerable to factors causing neurodegeneration in Parkinson’s disease (Chung et al., 2005); these observations suggest that Cbln1 may be involved in dopaminergic neuron pathology and provide a possible link to the results shown above for Bdnf…”
BackgroundResultInfluentialInflammation and neurodegenerative diseases
Griffin, W. S. T. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.470s · Cited by 351
Barrientos, R. M., Sprunger, D. B., Campeau, S., Higgins, E. A., Watkins, L. R., Rudy, J. W., & Maier, S. F. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00564-5 · Cited by 251 · cited 1×
“The loss of Bdnf during development causes hyperactivity and more pronounced hippocampal-dependent learning deficits (Monteggia et al., 2004) as well as hippocampaldependent memory impairment (Barrientos et al., 2003).”
BackgroundPorritt, M. J., Batchelor, P. E., & Howells, D. W. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2004.11.030 · Cited by 135 · cited 2×
“Indeed, Bdnf, which is also synthesized by dopaminergic neurons in the adult nigrostriatal pathway, shows a significantly reduced expression in the Parkinson’s disease substantia nigra, probably contributing to the impairment of nigral dopaminergic neurons and the development of Parkinson’s disease (Porritt et al., 20…”
Background
Cited by
Sanfilippo syndrome: A mini‐review
Valstar, M. J., Ruijter, G. J. G., van Diggelen, O. P., Poorthuis, B. J., & Wijburg, F. A. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0838-5 · Cited by 396
Lysosomal Storage Disease: Revealing Lysosomal Function and Physiology
Parkinson-Lawrence, E. J., Shandala, T., Prodoehl, M., Plew, R., Borlace, G. N., & Brooks, D. A. (2010) · Physiology · doi:10.1152/physiol.00041.2009 · Cited by 220
“mucopolysaccharidosis neuropathology (19, 114, 118).”
McCarty, D. M., DiRosario, J., Gulaid, K., Muenzer, J., & Fu, H. (2009) · Gene Therapy · doi:10.1038/gt.2009.85 · Cited by 105
Oxidative stress in developmental brain disorders
Hayashi, M., Miyata, R., & Tanuma, N. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0653-2_21 · Cited by 56
Villani, G. R. D., Chierchia, A., Di Napoli, D., & Di Natale, P. (2012) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-011-9403-8 · Cited by 15
“2009), as well as alterations of FGF and neurotrophins (Li et al. 2002; Villani et al. 2007).”
BackgroundMethodSelf-citationNovel grooved substrata stimulate macrophage fusion, CCL2 and MMP‐9 secretion
Moon, H., Cremmel, C. V. M., Kulpa, A., Jaeger, N. A. F., Kappelhoff, R., Overall, C. M., Waterfield, J. D., & Brunette, D. M. (2016) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35757 · Cited by 14
Metadata
- Authors
- Villani, G. R. D., Gargiulo, N., Faraonio, R., Castaldo, S., Gonzalez y Reyero, E., & Di Natale, P.
- Venue
- Journal of Neuroscience Research
- Publisher
- Wiley
- Published
- 2006-11-30
- Volume
- 85
- Issue
- 3
- Pages
- 612-622
- ISSN
- 0360-4012 (ISSN-L)
- 1097-4547
- OpenAlex
- W2161238216
- Cited by
- 126
- References
- 6
- FWCI
- 2.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.